Related references
Note: Only part of the references are listed.Pancreatic cancer stem cells: New insight into a stubborn disease
Han-xiang Zhan et al.
CANCER LETTERS (2015)
Cancer Stem Cells: Targeting the Roots of Cancer, Seeds of Metastasis, and Sources of Therapy Resistance
Valery Adorno-Cruz et al.
CANCER RESEARCH (2015)
Resveratrol Attenuates Intermittent Hypoxia-Induced Macrophage Migration to Visceral White Adipose Tissue and Insulin Resistance in Male Mice
Alba Carreras et al.
ENDOCRINOLOGY (2015)
JNK suppression of chemotherapeutic agents-induced ROS confers chemoresistance on pancreatic cancer stem cells
Shuhei Suzuki et al.
ONCOTARGET (2015)
Resveratrol decreases fructose-induced oxidative stress, mediated by NADPH oxidase via an AMPK-dependent mechanism
Pei-Wen Cheng et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Cancer Statistics, 2014
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
Hyperglycemia Regulates TXNIP/TRX/ROS Axis via p38 MAPK and ERK Pathways in Pancreatic Cancer
Wei Li et al.
CURRENT CANCER DRUG TARGETS (2014)
Cancer stem cells - important players in tumor therapy resistance
Selcuk Colak et al.
FEBS JOURNAL (2014)
Resveratrol plays dual roles in pancreatic cancer cells
Lei Yang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2014)
Hyperglycemia, a Neglected Factor during Cancer Progression
Wanxing Duan et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Hyperglycemia as a Risk Factor for Cancer Progression
Tae Young Ryu et al.
DIABETES & METABOLISM JOURNAL (2014)
A phase 2 study of SRT501 (resveratrol) with bortezomib for patients with relapsed and or refractory multiple myeloma
Rakesh Popat et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Adenovirus vector-mediated Gli1 siRNA induces growth inhibition and apoptosis in human pancreatic cancer with Smo-dependent or Smo-independent Hh pathway activation in vitro and in vivo
Jiefang Guo et al.
CANCER LETTERS (2013)
Resveratrol induces apoptosis of pancreatic cancers cells by inhibiting miR-21 regulation of BCL-2 expression
P. Liu et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2013)
Resveratrol Inhibits the Epithelial-Mesenchymal Transition of Pancreatic Cancer Cells Via Suppression of the PI-3K/Akt/NF-κB Pathway
Wei Li et al.
CURRENT MEDICINAL CHEMISTRY (2013)
Resveratrol and Cancer Treatment: Is Hormesis a Yet Unsolved Matter?
Adriana Borriello et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Resveratrol Impedes the Stemness, Epithelial-Mesenchymal Transition, and Metabolic Reprogramming of Cancer Stem Cells in Nasopharyngeal Carcinoma through p53 Activation
Yao-An Shen et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2013)
Digalloylresveratrol, a novel resveratrol analog inhibits the growth of human pancreatic cancer cells
Philipp Saiko et al.
INVESTIGATIONAL NEW DRUGS (2013)
Microenvironmental regulation of tumor progression and metastasis
Daniela F. Quail et al.
NATURE MEDICINE (2013)
3,5,4′-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition
Jie-Heng Tsai et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
SIRT1 inhibits proliferation of pancreatic cancer cells expressing pancreatic adenocarcinoma up-regulated factor (PAUF), a novel oncogene, by suppression of β-catenin
Il-Rae Cho et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Insulin Resistance and Cancer Risk: An Overview of the Pathogenetic Mechanisms
Biagio Arcidiacono et al.
EXPERIMENTAL DIABETES RESEARCH (2012)
Resveratrol suppresses tumorigenicity and enhances radiosensitivity in primary glioblastoma tumor initiating cells by inhibiting the STAT3 axis
Yi-Ping Yang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
Resveratrol-induced apoptosis is enhanced in low pH environments associated with cancer
Uzma Shamim et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
Resveratrol engages AMPK to attenuate ERK and mTOR signaling in sensory neurons and inhibits incision-induced acute and chronic pain
Dipti V. Tillu et al.
MOLECULAR PAIN (2012)
Diverse mechanisms of growth inhibition by luteolin, resveratrol, and quercetin in MIA PaCa-2 cells: a comparative glucose tracer study with the fatty acid synthase inhibitor C75
Diane M. Harris et al.
METABOLOMICS (2012)
Synergistic effects of leucine and resveratrol on insulin sensitivity and fat metabolism in adipocytes and mice
Antje Bruckbauer et al.
NUTRITION & METABOLISM (2012)
Current knowledge on pancreatic cancer
Juan Iovanne et al.
FRONTIERS IN ONCOLOGY (2012)
Resveratrol and cellular mechanisms of cancer prevention
Yogeshwer Shukla et al.
RESVERATROL AND HEALTH (2011)
Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2-Keap1 signaling
P. Palsamy et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients
Pal Brasnyo et al.
BRITISH JOURNAL OF NUTRITION (2011)
Diabetes and risk of pancreatic cancer: a pooled analysis of three large case-control studies
Donghui Li et al.
CANCER CAUSES & CONTROL (2011)
Resveratrol inhibits the epidermal growth factor-induced epithelial mesenchymal transition in MCF-7 cells
Daniele Vergara et al.
CANCER LETTERS (2011)
Phase I Randomized, Double-Blind Pilot Study of Micronized Resveratrol (SRT501) in Patients with Hepatic Metastases-Safety, Pharmacokinetics, and Pharmacodynamics
Lynne M. Howells et al.
CANCER PREVENTION RESEARCH (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Effect of food on the pharmacokinetic profile of trans-resveratrol
M. Vaz-da-Silva et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2011)
Effects of phytochemicals on ionization radiation-mediated carcinogenesis and cancer therapy
Dhanya Nambiar et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2011)
Resveratrol Inhibits Proliferation and Induces Apoptosis through the Hedgehog Signaling Pathway in Pancreatic Cancer Cell
Wenhui Mo et al.
PANCREATOLOGY (2011)
Resveratrol Inhibits Pancreatic Cancer Stem Cell Characteristics in Human and KrasG12D Transgenic Mice by Inhibiting Pluripotency Maintaining Factors and Epithelial-Mesenchymal Transition
Sharmila Shankar et al.
PLOS ONE (2011)
Resveratrol Inhibits Growth of Orthotopic Pancreatic Tumors through Activation of FOXO Transcription Factors
Sanjit K. Roy et al.
PLOS ONE (2011)
Resveratrol Modulates Drug- and Carcinogen-Metabolizing Enzymes in a Healthy Volunteer Study
H-H. Sherry Chow et al.
CANCER PREVENTION RESEARCH (2010)
Repeat Dose Study of the Cancer Chemopreventive Agent Resveratrol in Healthy Volunteers: Safety, Pharmacokinetics, and Effect on the Insulin-like Growth Factor Axis
Victoria A. Brown et al.
CANCER RESEARCH (2010)
Clinical Pharmacology of Resveratrol and Its Metabolites in Colorectal Cancer Patients
Ketan R. Patel et al.
CANCER RESEARCH (2010)
Insulin resistance and cancer: Epidemiological evidence
Shoichiro Tsugane et al.
CANCER SCIENCE (2010)
Steady-State Pharmacokinetics and Tolerability of Trans-Resveratrol 2000 mg Twice Daily with Food, Quercetin and Alcohol (Ethanol) in Healthy Human Subjects
Charles la Porte et al.
CLINICAL PHARMACOKINETICS (2010)
Digalloylresveratrol, a new phenolic acid derivative induces apoptosis and cell cycle arrest in human HT-29 colon cancer cells
Astrid Bernhaus et al.
CANCER LETTERS (2009)
Antitumor effects of KITC, a new resveratrol derivative, in AsPC-1 and BxPC-3 human pancreatic carcinoma cells
Astrid Bernhaus et al.
INVESTIGATIONAL NEW DRUGS (2009)
Targeting the phosphoinositide 3-kinase pathway in cancer
Pixu Liu et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Resveratrol inhibits heregulin-β1-mediated matrix metalloproteinase-9 expression and cell invasion in human breast cancer cells
Feng-Yao Tang et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2008)
The insulin-suppressive effect of resveratrol - An in vitro and in vivo phenomenon
Tomasz Szkudelski
LIFE SCIENCES (2008)
Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent
David J. Boocock et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Resveratrol stimulates AMP kinase activity in neurons
Biplab Dasgupta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-κB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells
Anjana Bhardwaj et al.
BLOOD (2007)
Resveratrol binds to the sulfonylurea receptor (SUR) and induces apoptosis in a SUR subtype-specific manner
Annette Hambrock et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Resveratrol inhibits Src and Stat3 signaling and induces the apoptosis of malignant cells containing activated Stat3 protein
A Kotha et al.
MOLECULAR CANCER THERAPEUTICS (2006)
From chemoprevention to chemotherapy: common targets and common goals
BB Aggarwal et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2004)
Sensitization for anticancer drug-induced apoptosis by the chemopreventive agent resveratrol
S Fulda et al.
ONCOGENE (2004)
Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis
SP Thayer et al.
NATURE (2003)
Hedgehog signaling in pancreas development
M Hebrok
MECHANISMS OF DEVELOPMENT (2003)
Stat3 and NF-κB activation prevents apoptosis in pancreatic carcinogenesis
FR Greten et al.
GASTROENTEROLOGY (2002)
Stem cells, cancer, and cancer stem cells
T Reya et al.
NATURE (2001)
Share Paper
